Home | Drugs Approvals and Trials

Drugs Approvals and Trials

Yale researchers test drug for Wilson Disease in clinical trial

A copper ring, known as Kayser Fleischer ring, appears in the Descemet's membrane of the cornea of a Wilson disease patient. (Image ...

FDA approves first generic Copaxone to treat multiple sclerosis

The U.S. Food and Drug Administration today approved the first generic version of Copaxone (glatiramer acetate injection), used to treat patients with ...

NIH launches largest clinical trial focused on HIV-related cardiovascular disease

Researchers have begun enrolling participants in a multicenter international clinical trial to test whether statin administration can reduce the risk for major adverse cardiovascular events, such as heart attacks, strokes, and heart disease, in people with HIV infection. The trial is supported by the National Institutes of Health’s National Heart, Lung, and Blood Institute (NHLBI) and National Institute of Allergy and Infectious Diseases (NIAID). ... Full story

On the way to a new tuberculosis vaccine

VPM1002 is being tested in clinical trials as a tuberculosis vaccine in newborns and as a drug against cancer of the bladder ... Full story

Cold Spring Harbor Laboratory and GSK to develop diabetes and obesity therapeutic

Cold Spring Harbor, NY -- Cold Spring Harbor Laboratory (CSHL) today announced a collaboration with GSK to develop a treatment for obesity and type 2 diabetes. ... Full story

FDA approves new antibacterial drug Avycaz

The U.S. Food and Drug Administration today approved Avycaz (ceftazidime-avibactam), a new antibacterial drug product, to treat adults with complicated intra-abdominal infections (cIAI), in combination with metronidazole, and complicated urinary tract infections (cUTI), including kidney infections (pyelonephritis), who have limited or no alternative treatment options. ... Full story

FDA approves closure system to permanently treat varicose veins

Device is first to use adhesive to cut off blood supply ... Full story

The Ottawa Hospital leads first Canadian clinical trial of mesenchymal stem cell therapy for multiple sclerosis

The Multiple Sclerosis Society of Canada and the Multiple Sclerosis Scientific Research Foundation announced today a $4.2 million grant to support the first Canadian clinical trial of mesenchymal stem cell therapy for multiple sclerosis (MS), led by Dr. Mark S. Freedman of The Ottawa Hospital and the University of Ottawa. ... Full story

FDA approves first generic esomeprazole

The U.S. Food and Drug Administration today approved the first generic version of Nexium (esomeprazole magnesium delayed-release capsules) to treat gastroesophageal reflux disease (GERD) in adults and children ages 1 and older. Esomeprazole is a proton pump inhibitor that reduces the amount of acid in the stomach. ... Full story

Mount Sinai Launches Artificial Pancreas Research Study

A newly launched clinical research study at the Icahn School of Medicine at Mount Sinai is examining whether an artificial pancreas (AP) can prevent too low blood sugar levels or hypoglycemia in patients with type 1 diabetes (T1D) as they sleep. ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 516 | displaying: 1 - 10